| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.33 | 4e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |